Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy

Loading...
Thumbnail Image

Full text at PDC

Publication date

2009

Advisors (or tutors)

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

John Wiley & Sons
Citations
Google Scholar

Citation

Velasco, G., Verfaillie, T., Salazar, M., & Agostinis, P. (2010). [Rev. of Linking ER stress to autophagy: Potential implications for cancer therapy]. International Journal of Cell Biology. https://doi.org/10.1155/2010/930509

Abstract

Different physiological and pathological conditions can perturb protein folding in the endoplasmic reticulum, leading to a condition known as ER stress. ER stress activates a complex intracellular signal transduction pathway, called unfolded protein response (UPR). The UPR is tailored essentially to reestablish ER homeostasis also through adaptive mechanisms involving the stimulation of autophagy. However, when persistent, ER stress can switch the cytoprotective functions of UPR and autophagy into cell death promoting mechanisms. Recently, a variety of anticancer therapies have been linked to the induction of ER stress in cancer cells, suggesting that strategies devised to stimulate its prodeath function or block its prosurvival function, could be envisaged to improve their tumoricidial action. A better understanding of the molecular mechanisms that determine the final outcome of UPR and autophagy activation by chemotherapeutic agents, will offer new opportunities to improve existing cancer therapies as well as unravel novel targets for cancer treatment.

Research Projects

Organizational Units

Journal Issue

Description

The work from the author’s laboratories was supported by Grants to P.A. from the K.U.Leuven (OT49/06), F.W.O Flanderen (G.0661.09), and Interuniversity Attraction Pole (IAP) 6/18 initiated by the Belgian State, Science Policy Office as well as by Grants to G.V. from Spanish Ministry of Education and Science (MEC) (HF2005/0021 and SAF2006/00918), Santander-Complutense (PR34/07- 15856), Comunidad de Madrid (S-SAL/0261/2006), GW Pharmaceuticals, and Schering Plough (473/2008).

Keywords

Collections